New insights into systemic sclerosis / / edited by Michal Tomcik.
Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic fe...
Saved in:
: | |
---|---|
TeilnehmendeR: | |
Place / Publishing House: | London, United Kingdom : : IntechOpen,, [2019] ©2019 |
Year of Publication: | 2019 |
Language: | English |
Physical Description: | 1 online resource (160 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544010404498 |
---|---|
ctrlnum |
(CKB)4920000000094428 (NjHacI)994920000000094428 (oapen)https://directory.doabooks.org/handle/20.500.12854/54593 (EXLCZ)994920000000094428 |
collection |
bib_alma |
record_format |
marc |
spelling |
Michal Tomcik auth New insights into systemic sclerosis / edited by Michal Tomcik. IntechOpen 2019 London, United Kingdom : IntechOpen, [2019] ©2019 1 online resource (160 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 19, 2022). Includes bibliographical references. Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic feature that affects the skin and visceral organs. Life expectancy of scleroderma patients has improved over recent years, mainly because of better treatment of organ involvement and complications; however, no curative disease-modifying therapies exist to date. This book aims to provide students, trainees, rheumatologists, and other specialists interested in this disease with a comprehensive overview of novel pathogenetic mechanisms, management approaches, and therapeutic targets of several major vascular and fibrotic manifestations, and is useful insight into a number of usually neglected aspects of scleroderma. English Systemic scleroderma. Medicine Immunopathology Immunology Allergology and Rheumatology Health Sciences 1-83962-204-0 Tomcik, Michal , editor. |
language |
English |
format |
eBook |
author |
Michal Tomcik |
spellingShingle |
Michal Tomcik New insights into systemic sclerosis / |
author_facet |
Michal Tomcik Tomcik, Michal , |
author_variant |
m t mt |
author2 |
Tomcik, Michal , |
author2_variant |
m t mt |
author2_role |
TeilnehmendeR |
author_sort |
Michal Tomcik |
title |
New insights into systemic sclerosis / |
title_full |
New insights into systemic sclerosis / edited by Michal Tomcik. |
title_fullStr |
New insights into systemic sclerosis / edited by Michal Tomcik. |
title_full_unstemmed |
New insights into systemic sclerosis / edited by Michal Tomcik. |
title_auth |
New insights into systemic sclerosis / |
title_new |
New insights into systemic sclerosis / |
title_sort |
new insights into systemic sclerosis / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2019 |
physical |
1 online resource (160 pages) : illustrations |
isbn |
1-83962-206-7 1-83962-205-9 1-83962-204-0 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC924 |
callnumber-sort |
RC 3924.5 S34 N49 42019 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.544 |
dewey-sort |
3616.544 |
dewey-raw |
616.544 |
dewey-search |
616.544 |
work_keys_str_mv |
AT michaltomcik newinsightsintosystemicsclerosis AT tomcikmichal newinsightsintosystemicsclerosis |
status_str |
n |
ids_txt_mv |
(CKB)4920000000094428 (NjHacI)994920000000094428 (oapen)https://directory.doabooks.org/handle/20.500.12854/54593 (EXLCZ)994920000000094428 |
carrierType_str_mv |
cr |
is_hierarchy_title |
New insights into systemic sclerosis / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548743305789440 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01062nam a2200313 i 4500</leader><controlfield tag="001">993544010404498</controlfield><controlfield tag="005">20221019220821.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221019s2019 enka ob 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83962-206-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-83962-205-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094428</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994920000000094428</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/54593</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094428</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC924.5.S34</subfield><subfield code="b">.N49 2019</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.544</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Michal Tomcik</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">New insights into systemic sclerosis /</subfield><subfield code="c">edited by Michal Tomcik.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2019</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2019]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2019</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (160 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 19, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Systemic sclerosis (scleroderma) is an incurable connective tissue disease of unknown etiology. Three key processes play a pivotal role in the pathogenesis: immune dysregulation and inflammation, endothelial injury and vasculopathy, and fibrosis. Tissue fibrosis is the dominant and characteristic feature that affects the skin and visceral organs. Life expectancy of scleroderma patients has improved over recent years, mainly because of better treatment of organ involvement and complications; however, no curative disease-modifying therapies exist to date. This book aims to provide students, trainees, rheumatologists, and other specialists interested in this disease with a comprehensive overview of novel pathogenetic mechanisms, management approaches, and therapeutic targets of several major vascular and fibrotic manifestations, and is useful insight into a number of usually neglected aspects of scleroderma.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Systemic scleroderma.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunopathology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Immunology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Allergology and Rheumatology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Health Sciences</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-83962-204-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomcik, Michal ,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 21:26:42 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5351662700004498&Force_direct=true</subfield><subfield code="Z">5351662700004498</subfield><subfield code="b">Available</subfield><subfield code="8">5351662700004498</subfield></datafield></record></collection> |